Synergistic effects of a cremophor EL drug delivery system and its U0126 cargo in an ex vivo model
Neuroprotection has proven clinically unsuccessful in subarachnoid hemorrhage. We believe that this is because the major component in the early damage pathway, the vascular wall, has not been given the necessary focus. U0126 is a potent inhibitor of vascular phenotypical changes, exemplified by func...
Saved in:
Main Authors: | S. T. Christensen (Author), A. S. Grell (Author), S. E. Johansson (Author), C. M. Andersson (Author), L. Edvinsson (Author), K. A. Haanes (Author) |
---|---|
Format: | Book |
Published: |
Taylor & Francis Group,
2019-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
U0126: Not only a MAPK kinase inhibitor
by: Yijie You, et al.
Published: (2022) -
The MEK Inhibitor Trametinib Improves Outcomes following Subarachnoid Haemorrhage in Female Rats
by: Jesper Peter Bömers, et al.
Published: (2022) -
Formulation and in vivo assessment of terconazole-loaded polymeric mixed micelles enriched with Cremophor EL as dual functioning mediator for augmenting physical stability and skin delivery
by: Wessam H. Abd-Elsalam, et al.
Published: (2018) -
U0126 and BAY11-7082 Inhibit the Progression of Endometriosis in a Rat Model by Suppressing the MEK/ERK/NF-?B Pathway
by: Fang Wang, et al.
Published: (2023) -
Enhancement of the Oral Bioavailability of Fexofenadine Hydrochloride via Cremophor® El-Based Liquisolid Tablets
by: Soad Ali Yehia, et al.
Published: (2015)